Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Alpha blockaders--first or second line antihypertensive agents?]

P Lund-Johansen1, I Hjermann, B M Iversen

  • 1Hjerteavdelingen, Haukeland sykehus, Bergen.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 28, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selected Sumaries.

Acta clinica Belgica·2016
Same author

Lifelong benefits on myocardial infarction mortality: 40-year follow-up of the randomized Oslo diet and antismoking study.

Journal of internal medicine·2016
Same author

A lower reduction in umbilical artery pulsatility in mid-pregnancy predicts higher infant blood pressure six months after birth.

Acta paediatrica (Oslo, Norway : 1992)·2015
Same author

Adenosine sensitization after angiotensin II stimulation in afferent arterioles from normal rats does not occur during two-kidney, one-clip hypertension.

Acta physiologica (Oxford, England)·2010
Same author

Impaired weight gain predicts risk of late death after surgery for congenital heart defects.

Archives of disease in childhood·2008
Same author

The estimated number of patients with adult congenital heart defects in Norway.

Scandinavian journal of medicine & science in sports·2007
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Alpha-receptor blockers effectively lower blood pressure by targeting alpha 1-receptors without impacting heart function. These medications also improve lipid profiles and do not affect electrolytes, glucose, or uric acid metabolism.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Alpha-receptor blockers are a class of drugs used to treat hypertension.
  • Their mechanism involves blocking alpha 1-receptors in vascular smooth muscle.

Purpose of the Study:

  • To summarize the effects of alpha-receptor blockers on blood pressure and cardiovascular health.
  • To highlight their metabolic and pulmonary effects.
  • To outline appropriate clinical use and contraindications.

Main Methods:

  • Review of existing studies on alpha-receptor blockers.
  • Analysis of their impact on blood pressure, lipid profiles, and metabolic parameters.
  • Evaluation of safety and efficacy in different patient populations.

Main Results:

Related Experiment Videos

  • Alpha-receptor blockers reduce blood pressure by blocking alpha 1-receptors, without impairing cardiac function.
  • They improve lipid profiles by reducing triglycerides and increasing HDL/LDL cholesterol ratio.
  • No adverse effects on electrolytes, glucose, uric acid, or pulmonary function were observed.

Conclusions:

  • Alpha-receptor blockers are a safe and effective first-line antihypertensive treatment when used appropriately.
  • Consideration of potential side effects like transient tachycardia is necessary.
  • Contraindicated in coronary heart disease patients not on beta-blockade.